Literature DB >> 31186851

Hepatitis C viral infection in patients with cirrhosis.

Ranjeeta Bahirwani1, K Rajender Reddy1.   

Abstract

Entities:  

Year:  2012        PMID： 31186851      PMCID： PMC6499264          DOI： 10.1002/cld.43

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  19 in total

Review 1.  Pathogenesis, natural history, treatment, and prevention of hepatitis C.

Authors:  T J Liang; B Rehermann; L B Seeff; J H Hoofnagle
Journal:  Ann Intern Med       Date:  2000-02-15       Impact factor: 25.391

2.  Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis.

Authors:  E J Heathcote; M L Shiffman; W G Cooksley; G M Dusheiko; S S Lee; L Balart; R Reindollar; R K Reddy; T L Wright; A Lin; J Hoffman; J De Pamphilis
Journal:  N Engl J Med       Date:  2000-12-07       Impact factor: 91.245

3.  The association between hepatitis C infection and survival after orthotopic liver transplantation.

Authors:  Lisa M Forman; James D Lewis; Jesse A Berlin; Harold I Feldman; Michael R Lucey
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

Review 4.  A review of the treatment of chronic hepatitis C virus infection in cirrhosis.

Authors:  Elena Vezali; Alessio Aghemo; Massimo Colombo
Journal:  Clin Ther       Date:  2010-12       Impact factor: 3.393

5.  Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study.

Authors:  Savino Bruno; Andrea Crosignani; Corinna Facciotto; Sonia Rossi; Luigi Roffi; Alessandro Redaelli; Roberto de Franchis; Piero Luigi Almasio; Patrick Maisonneuve
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

6.  Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model.

Authors:  Sammy Saab; Douglas R Hunt; Michael A Stone; Amy McClune; Myron J Tong
Journal:  Liver Transpl       Date:  2010-06       Impact factor: 5.799

7.  Pegylated interferon alpha-2b plus ribavirin for naive patients with HCV-related cirrhosis.

Authors:  Annarosa Floreani; Vincenzo Baldo; Erik Rosa Rizzotto; Isabella Carderi; Tatjana Baldovin; Eliseo Minola
Journal:  J Clin Gastroenterol       Date:  2008-07       Impact factor: 3.062

8.  Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study.

Authors:  Jose A Carrión; Eva Martínez-Bauer; Gonzalo Crespo; Santseharay Ramírez; Sofia Pérez-del-Pulgar; Juan Carlos García-Valdecasas; Miquel Navasa; Xavier Forns
Journal:  J Hepatol       Date:  2008-12-29       Impact factor: 25.083

Review 9.  Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors.

Authors:  Sharif B Missiha; Mario Ostrowski; E Jenny Heathcote
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

10.  Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis.

Authors:  Savino Bruno; Mitchell L Shiffman; Stuart K Roberts; Edward J Gane; Diethelm Messinger; Stephanos J Hadziyannis; Patrick Marcellin
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.